Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
|2||Active, not recruiting||
Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A
† Study has passed its completion date and status has not been verified in more than two years.